Introducing self-sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland.
Acta Obstet Gynecol ScandJun 4, 2026 (epub)
Saara Kyllönen, Satu Saloranta, Saara Kares et al.
✦ AI-curated · Sources linked
In 30 seconds
This clinical trial evaluated the feasibility and acceptability of self-sampling for cervical cancer screening among women in Pirkanmaa, Finland, who did not respond to initial invitations. Out of 16,289 reminder letters, 329 kits were ordered, and 304 samples were returned, revealing an HPV detection rate of 6.9%. The study indicates strong acceptability of self-sampling.
Key findings
- Only 1.9% of reminder letters resulted in returned samples, with 304 out of 16,289 kits sent back.
- HPV was detected in 6.9% of the samples analyzed.
- Most participants found self-sampling easy and comfortable, with nearly all recommending it to others.
Why it matters
The study highlights the potential of self-sampling to improve participation in cervical cancer screening, particularly among women who are less likely to attend traditional screening methods. This could lead to earlier detection and better outcomes in cervical cancer prevention.